Tobi (Tobramycin Nasal Spray) 300mg/5ml

TOBI Nasal Spray (300mg/5ml) is a prescription nasal spray used for bacterial infections. This UK-sourced treatment delivers targeted antibiotic action for upper respiratory conditions. Ideal for short-term use under medical guidance.

Strength

300mg/5ml

Pack Size

28s

Manufacturer / TM Owner

Mylan Pharma

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Tobramycin nasal spray is primarily used to treat bacterial infections in the nasal passages and sinuses. It works by stopping the growth of bacteria that cause infections. This form is often prescribed for chronic sinusitis or nasal polyps when other treatments are ineffective. Always follow your healthcare provider’s instructions for use.

Side Effects

Users may notice a reduction in nasal congestion, discharge, or sinus pressure as the medication takes effect. Some individuals report temporary mild irritation or dryness in the nasal passages during use. These effects are typically mild and resolve with continued treatment.

Precautions & Warnings

Keep the spray away from eyes and open wounds. Do not use if you have a known allergy to tobramycin or other aminoglycosides. Store at room temperature, away from moisture and heat. Discard any unused medication after the prescribed duration.

Avoid Interactions

This nasal spray has minimal systemic absorption, reducing the risk of interactions with oral or injectable medications. However, concurrent use of other nasal sprays should be spaced at least 5 minutes apart. Always inform your healthcare provider about all medications you are using.

Frequently Asked Questions

TOBI nasal spray is used to treat bacterial infections in the nasal passages and sinuses, such as chronic sinusitis or nasal polyps.

Store TOBI nasal spray at room temperature, away from moisture and direct heat. Keep the bottle tightly closed when not in use.

Some users may experience mild nasal irritation or dryness. Rarely, allergic reactions may occur; discontinue use and consult a healthcare provider if symptoms worsen.

This medication is typically prescribed for short-term use. Prolonged use should be monitored by a healthcare provider to avoid potential risks.

TOBI nasal spray is manufactured by Mylan Pharma and sourced from the UK.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.